Project Details
Description
A Phase 3, Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy and Safety of Leuprolide Acetate 11.25 and 30 mg Formulations in Children with Central Precocious Puberty
| Status | Finished |
|---|---|
| Effective start/end date | 2/18/08 → 12/31/11 |
Funding
- ABBOTT LABORATORIES
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.